HWM
JAZZ icon

Hemington Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Hemington Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$12K Buy
94
+20
+27% +$2.4K ﹤0.01% 813
2025
Q2 		$7K Sell
74
-11
-13% -$1.2K ﹤0.01% 985
2025
Q1 		$10K Buy
85
+29
+52% +$3.78K ﹤0.01% 818
2024
Q4 		$6K Buy
56
+23
+70% +$2.71K ﹤0.01% 953
2024
Q3 		$3K Buy
+33
New +$3.62K ﹤0.01% 1078

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Hemington Wealth Management's JAZZ Position: Q3 2025 in Review

Hemington Wealth Management increased its Jazz Pharmaceuticals (JAZZ) stake by 27% in Q3 2025, buying an estimated $2.4K and bringing the position to 94 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #813.

Hemington Wealth Management first reported a position in JAZZ in Q3 2024 and has held it in 5 quarters since. 503 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • Hemington Wealth Management held 94 shares of Jazz Pharmaceuticals worth $12K as of Q3 2025.
  • Hemington Wealth Management bought 20 Jazz Pharmaceuticals shares in Q3 2025, an estimated $2.4K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #813 holding.
  • Hemington Wealth Management first reported a position in Jazz Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • 503 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.